Working… Menu

Endobronchial Ultrasound Guided Transbronchial Needle Aspiration Performed Under General Anesthesia Versus Moderate Sedation (EBUS-GA-MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01430962
Recruitment Status : Completed
First Posted : September 9, 2011
Last Update Posted : July 23, 2015
Information provided by (Responsible Party):
Roberto Casal, Baylor College of Medicine

Brief Summary:
The purpose of the study is to determine if there are any differences in yield or safety of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) (a type of bronchoscopy with biopsy) performed under general anesthesia versus moderate sedation.

Condition or disease
Mediastinal Lymphadenopathies Mediastinal Masses Hilar Lymphadenopathies

Layout table for study information
Study Type : Observational
Actual Enrollment : 149 participants
Time Perspective: Prospective
Official Title: Randomized Controlled Trial Comparing Endobronchial Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) Performed Under General Anesthesia Versus Conscious Sedation
Study Start Date : November 2011
Actual Primary Completion Date : July 2013
Actual Study Completion Date : February 2014

General Anesthesia
Patients will receive Total Intravenous Anesthesia (TIVA) with a combination of Propofol, Ketamine and neuromuscular blockade by anesthesia. Either an LMA or an ETT will be used to secure airway.
Moderate Sedation
Patients will receive moderate sedation given by the physician performing EBUS with a combination of Versed and Fentanyl per hospital protocol.

Primary Outcome Measures :
  1. Diagnostic Yield [ Time Frame: 24 months ]

Secondary Outcome Measures :
  1. Complications rate [ Time Frame: 24 months ]
  2. Time to recovery from anesthesia [ Time Frame: 24 months ]
  3. Tolerance to procedure [ Time Frame: 24 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult individuals with suspected mediastinal or hilar lymphadenopathies or masses referred for endobronchial ultrasound-guided biopsy.

Inclusion Criteria:

  • All patients over the age of 18, evaluated by pulmonary physician that require EBUS TBNA for sampling of hilar and/or mediastinal lymphadenopathies or masses
  • Patients should be considered eligible to undergo either CS or GA, without contraindications for either one of them, based on the assessment by the pulmonologist who will perform EBUS-TBNA

Exclusion Criteria:

  • Pregnancy or breastfeeding women
  • Patients deemed poor candidates for general anesthesia by the evaluating physician (e.g., severe coronary artery disease, COPD with FEV1 < 1 liter, uncontrolled hypertension, increased intracranial pressure, reaction to anesthetics)
  • Previous reaction to medications routinely used in conscious sedation
  • Patients with history of intolerance to either general anesthesia or conscious sedation
  • Dementia or other severe cognitive impairment causing inability to understand or consent to the procedure and study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01430962

Layout table for location information
United States, Texas
Michael E. DeBakey VA Medical Center
Houston, Texas, United States, 77030
Sponsors and Collaborators
Baylor College of Medicine
Layout table for investigator information
Principal Investigator: Roberto F. Casal, MD Baylor College of Medicine- Michael E. DeBakey VA Medical Center
Publications automatically indexed to this study by Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Roberto Casal, Assistant Professor of Medicine, Baylor College of Medicine Identifier: NCT01430962    
Other Study ID Numbers: H-27545
First Posted: September 9, 2011    Key Record Dates
Last Update Posted: July 23, 2015
Last Verified: July 2015
Keywords provided by Roberto Casal, Baylor College of Medicine:
mediastinal lymph nodes
mediastinal masses
moderate sedation
Additional relevant MeSH terms:
Layout table for MeSH terms
Lymphatic Diseases